PROSCA & BLADDR 2023

 

PROSCA & BLADDR 2023
J

Should Extended LND Still Be SOC for High-Risk Prostate Cancer?

By PROSCA & BLADDR 2023 FEATURING Jochen Walz
By PROSCA & BLADDR 2023 FEATURING Jochen Walz
0 views
January 12, 2024
Comments 0
Login to view comments. Click here to Login
PROSCA
11:22
PROSCA & BLADDR 2023

PCaGoal: Prostate Cancer Patients Football Team at FC Porto

Feat. D. Nunes-Carneiro
20:19
PROSCA & BLADDR 2023

The Power of Play: Enhancing Patients’ Health and Well-Being Through…

Feat. S. PóVoas
14:33
PROSCA & BLADDR 2023

Radioligand Therapy for Prostate Cancer: For Whom and When

Feat. K. Herrmann
17:40
PROSCA & BLADDR 2023

Updates on PARPi in Prostate Cancer

Feat. E. Castro
11:56
PROSCA & BLADDR 2023

Liquid Biopsy as a Treatment Selector in mCRPC

Feat. B. De Laere
24:15
PROSCA & BLADDR 2023

Updates on nmCRPC

Feat. A. Bossi
21:18
PROSCA & BLADDR 2023

Improving Psychological Well-Being of Advanced Prostate Cancer Patie…

Feat. T. Estapé
14:45
PROSCA & BLADDR 2023

QoL in Patients With Advanced Prostate Cancer Who Are Living Longer:…

Feat. D. Raggi
17:35
PROSCA & BLADDR 2023

Lifestyle & Prevention of Complications in Advanced Prostate Can…

Feat. A. Omlin
13:35
PROSCA & BLADDR 2023

De-Escalating Strategies in HSPC

Feat. B. Tombal
06:30
PROSCA & BLADDR 2023

How Should Prostate Cancer Be Diagnosed: Targeted Biopsies Alone Sho…

Feat. J. Stranne
10:06
PROSCA & BLADDR 2023

How Should Prostate Cancer Be Diagnosed: Targeted + Systematic Biopsy

Feat. R. van den Bergh
17:26
PROSCA & BLADDR 2023

Local Treatment of the Prostate in Synchronous mHSPC

Feat. A. Bossi
11:07
PROSCA & BLADDR 2023

Treatment Intensification of High-Risk BCR Prostate Cancer

Feat. A. Rannikko
17:07
PROSCA & BLADDR 2023

Systemic Therapy in mHSPC: Who Needs Treatment Intensification?

Feat. A. Bahl
12:27
PROSCA & BLADDR 2023

Clinical Implications of Genomic Alterations in Prostate Cancer

Feat. D. Olmos
12:17
PROSCA & BLADDR 2023

Is Metastasis-Directed Therapy for Prostate Cancer Still Experimenta…

Feat. T. Zilli
11:35
PROSCA & BLADDR 2023

Nodal Recurrences in Prostate Cancer: What Is the Optimal Approach?

Feat. P. Ost
12:12
PROSCA & BLADDR 2023

When Is RT Indicated for Prostate Cancer and Should We Add ADT?

Feat. P. Sargos
28:07
PROSCA & BLADDR 2023

Innovations in Nerve Sparing Robotic Prostatectomy

Feat. A. Tewari
16:55
PROSCA & BLADDR 2023

Intermediate to High-Risk Prostate Cancer: Who Needs Treatment Inten…

Feat. P. Ost
17:37
PROSCA & BLADDR 2023

Should Extended LND Still Be SOC for High-Risk Prostate Cancer?

Feat. J. Walz
08:30
PROSCA & BLADDR 2023

Translating New Data Into Clinical Practice: The Mirrors of Medicine…

Feat. H. Stoevelaar
19:38
PROSCA & BLADDR 2023

Prostate Cancer Screening and Organized Testing

Feat. A. Rannikko
30:12
PROSCA & BLADDR 2023

The Role of PSMA-PET/CT in Primary Staging, for Follow-Up After Radi…

Feat. K. Goffin